Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 661 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR New Blood Test Can Screen For Over 50 Cancers June 7, 2021 Liquid Biopsy Detects Brain Cancer and Early-Stage Kidney Cancer July 23, 2020 ΚΑΡΚΙΝΟΣ ΠΑΓΚΡΕΑΤΟΣ November 22, 2018 3…2…1…Countdown to Medicare Open Enrollment October 12, 2023 Load more HOT NEWS Breast Cancer Patient Is Accused of Having “Body Image Issues” After... Breast Cancer Death Rates Will Rise in Elderly EU Patients but... What to Expect During a Skin Cancer Screening ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large...
